168 related articles for article (PubMed ID: 19689416)
1. Structural and pharmacological features of phospholipases A2 from snake venoms.
de Paula RC; Castro HC; Rodrigues CR; Melo PA; Fuly AL
Protein Pept Lett; 2009; 16(8):899-907. PubMed ID: 19689416
[TBL] [Abstract][Full Text] [Related]
2. Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins.
Gutiérrez JM; Lomonte B
Toxicon; 2013 Feb; 62():27-39. PubMed ID: 23025922
[TBL] [Abstract][Full Text] [Related]
3. Purification and complete primary structure of the first PLA2 from Lachesis stenophrys (the Central American Bushmaster) snake venom.
de Assis EB; Estevão-Costa MI; do Carmo Valentim A; Silva-Neto A; Agostini Cotta G; Alvarenga Mudado M; Richardson M; Fortes-Dias CL
Protein J; 2008 Aug; 27(5):327-33. PubMed ID: 18473155
[TBL] [Abstract][Full Text] [Related]
4. Influence of quaternary conformation on the biological activities of the Asp49-phospholipases A2s from snake venoms.
Magro AJ; Fernandes CA; dos Santos JI; Fontes MR
Protein Pept Lett; 2009; 16(8):852-9. PubMed ID: 19689411
[TBL] [Abstract][Full Text] [Related]
5. Calcium-independent membrane damage by venom phospholipases A2.
de Oliveira AH; Aragão EA; Sá JM; Chioato L; Bugs-Bortoleto R; Ruller R; Ferreira TL; Ward RJ
Protein Pept Lett; 2009; 16(8):877-86. PubMed ID: 19689413
[TBL] [Abstract][Full Text] [Related]
6. Chemical modifications of phospholipases A2 from snake venoms: effects on catalytic and pharmacological properties.
Soares AM; Giglio JR
Toxicon; 2003 Dec; 42(8):855-68. PubMed ID: 15019487
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nicotinic acetylcholine receptors, a novel facet in the pleiotropic activities of snake venom phospholipases A2.
Vulfius CA; Kasheverov IE; Starkov VG; Osipov AV; Andreeva TV; Filkin SY; Gorbacheva EV; Astashev ME; Tsetlin VI; Utkin YN
PLoS One; 2014; 9(12):e115428. PubMed ID: 25522251
[TBL] [Abstract][Full Text] [Related]
8. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential.
Marcussi S; Sant'Ana CD; Oliveira CZ; Rueda AQ; Menaldo DL; Beleboni RO; Stabeli RG; Giglio JR; Fontes MR; Soares AM
Curr Top Med Chem; 2007; 7(8):743-56. PubMed ID: 17456038
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics.
Faure G; Gowda VT; Maroun RC
BMC Struct Biol; 2007 Dec; 7():82. PubMed ID: 18062812
[TBL] [Abstract][Full Text] [Related]
10. Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region.
Fujisawa D; Yamazaki Y; Lomonte B; Morita T
Biochem J; 2008 May; 411(3):515-22. PubMed ID: 18251716
[TBL] [Abstract][Full Text] [Related]
11. Snake venom phospholipases A2: a new class of antitumor agents.
Rodrigues RS; Izidoro LF; de Oliveira RJ; Sampaio SV; Soares AM; Rodrigues VM
Protein Pept Lett; 2009; 16(8):894-8. PubMed ID: 19689415
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of phospholipase A2 (trimorphin) from the venom of the Sonoran Lyre Snake Trimorphodon biscutatus lambda (family Colubridae).
Huang P; Mackessy SP
Toxicon; 2004 Jul; 44(1):27-36. PubMed ID: 15225559
[TBL] [Abstract][Full Text] [Related]
13. The intriguing phospholipases A2 homologues: relevant structural features on myotoxicity and catalytic inactivity.
dos Santos JI; Fernandes CA; Magro AJ; Fontes MR
Protein Pept Lett; 2009; 16(8):887-93. PubMed ID: 19689414
[TBL] [Abstract][Full Text] [Related]
14. Venom neutralization by purified bioactive molecules: Synthetic peptide derivatives of the endogenous PLA(2) inhibitory protein PIP (a mini-review).
Thwin MM; Samy RP; Satyanarayanajois SD; Gopalakrishnakone P
Toxicon; 2010 Dec; 56(7):1275-83. PubMed ID: 20045432
[TBL] [Abstract][Full Text] [Related]
15. Rapid Identification of Phospholipase A₂ Transcripts from Snake Venoms.
Jia Y; Olvera P; Rangel F; Mendez B; Reddy S
Toxins (Basel); 2019 Jan; 11(2):. PubMed ID: 30691065
[TBL] [Abstract][Full Text] [Related]
16. Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action.
Montecucco C; Gutiérrez JM; Lomonte B
Cell Mol Life Sci; 2008 Sep; 65(18):2897-912. PubMed ID: 18563294
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis.
Kang TS; Georgieva D; Genov N; Murakami MT; Sinha M; Kumar RP; Kaur P; Kumar S; Dey S; Sharma S; Vrielink A; Betzel C; Takeda S; Arni RK; Singh TP; Kini RM
FEBS J; 2011 Dec; 278(23):4544-76. PubMed ID: 21470368
[TBL] [Abstract][Full Text] [Related]
18. Evolution of an arsenal: structural and functional diversification of the venom system in the advanced snakes (Caenophidia).
Fry BG; Scheib H; van der Weerd L; Young B; McNaughtan J; Ramjan SF; Vidal N; Poelmann RE; Norman JA
Mol Cell Proteomics; 2008 Feb; 7(2):215-46. PubMed ID: 17855442
[TBL] [Abstract][Full Text] [Related]
19. Sequence of a cDNA encoding a snake venom phospholipase A2.
Guignery-Frelat G; Ducancel F; Ménez A; Boulain JC
Nucleic Acids Res; 1987 Jul; 15(14):5892. PubMed ID: 3615209
[No Abstract] [Full Text] [Related]
20. Endogenous inhibitors of snake venom phospholipases A(2) in the blood plasma of snakes.
Fortes-Dias CL
Toxicon; 2002 May; 40(5):481-4. PubMed ID: 11821118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
